🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...
Status
Completed
Location
205.419.01058 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01172821
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10453
Start Date
2013-01
Trial ID
NCT01772368
Treatments Being Tested
New formulations of extrafine particles of long acting beta-2 agonists+inha...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT01255579
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy of flutica...
Status
Completed
Location
Teva Investigational Site 12397
Start Date
2014-06
Trial ID
NCT02139644
Treatments Being Tested
This study will be conducted as a randomized, double blind, double dummy tw...
Status
Completed
Location
Antwerp University Hospital
Start Date
2013-03
Trial ID
NCT01795664
The primary objective of the study is to evaluate the long-term safety of f...
Status
Completed
Location
Teva Investigational Site 12068
Start Date
2014-07
Trial ID
NCT02175771
Treatments Being Tested
This study is a multicenter, stratified, randomized, active control, double...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-05-01
Trial ID
NCT02113436
Treatments Being Tested
The purpose of this study is to evaluate the site and mechanisms responsibl...
Status
Recruiting
Location
Arthur F Gelb Medical Corporation
Start Date
2007-10-25
Trial ID
NCT00576069
Treatments Being Tested
The aim of this trial is to evaluate the efficacy and safety of 2.5 and 5 m...
Status
Completed
Location
205.418.01020 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01172808